Oyster Plus Traditional Medicine From China Banned

KUALA LUMPUR, Jan 19 (Bernama) -- The Drug Control Authority (DCA) in the Health Ministry has cancelled the registration of "Oyster Plus", a traditional medical product imported from China, after it was found to contain tadalafil, a prescribed drug to treat men with erectile dysfunction.
A statement by DCA Wednesday said tadalafil could be harmful to health, especially to patients with heart conditions or diabetes.
It said the drug could also interact with other medicines resulting in serious adverse effects such as the lowering of blood pressure if used together with some antihypertensive drugs.
The Chinese drug authority had been informed about the detection of tadalafil in Oyster Plus, it added.
The product is imported by Global Like Sdn Bhd and distributed by Smart Naco Sdn Bhd. The statement said people possessing the product must immediately stop selling, distributing or using it, and should surrender it to the Pharmacy Enforcement Branch in the respective state.
Sellers of the product can be charged under the Control of Drugs and Cosmetics Regulations 1984.
Individual offenders are liable to a fine up to RM25,000 or three years jail or both for the first offence and RM50,000 fine or five years jail for the second and subsequent offences.
A company found guilty can be fined up to RM50,000 for the first offence and RM100,000 for the second and subsequent offences.